Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other


COLES N ANTHONY Create: Alert

All | News | Filings
Date FiledTypeDescription
07/13/2023 4 COLES N ANTHONY (Director) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Sold 50,000 shares @ $30.0268, valued at $1.5M
Exercised 50,000 options to buy @ $3.5, valued at $175k
07/11/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/08/2023 4 COLES N ANTHONY (CEO and Chairperson) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Sold 37,568 shares @ $31.3636, valued at $1.2M
Sold 12,132 shares @ $31.7579, valued at $385.3k
Sold 300 shares @ $32.93, valued at $9.9k
Exercised 50,000 options to buy @ $3.5, valued at $175k
05/04/2023 144 Form 144 - Report of proposed sale of securities:
04/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/06/2023 4 COLES N ANTHONY (CEO and Chairperson) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Sold 47,000 shares @ $27.1144, valued at $1.3M
Sold 3,000 shares @ $27.19, valued at $81.6k
Exercised 47,000 options to buy @ $3.5, valued at $164.5k
Exercised 3,000 options to buy @ $3.5, valued at $10.5k
02/08/2023 4 COLES N ANTHONY (CEO and Chairperson) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Sold 42,058 shares @ $33.0437, valued at $1.4M
Sold 7,942 shares @ $33.5745, valued at $266.6k
Granted 243,042 options to buy @ $34.41, valued at $8.4M
Granted 61,762 restricted stock units @ $0
Exercised 50,000 options to buy @ $3.5, valued at $175k
01/06/2023 4 COLES N ANTHONY (CEO and Chairperson) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Sold 49,500 shares @ $29.9294, valued at $1.5M
Sold 500 shares @ $30.732, valued at $15.4k
Exercised 50,000 options to buy @ $3.5, valued at $175k
01/05/2023 4 COLES N ANTHONY (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Granted 165 shares @ $0
Granted 1,929 options to buy @ $725.89, valued at $1.4M
12/30/2022 4 COLES N ANTHONY (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 181 shares @ $707.87, valued at $128.1k
Sold 1 shares @ $709.92, valued at $709.9
Sold 679 shares @ $710.63, valued at $482.5k
Sold 100 shares @ $711.95, valued at $71.2k
Sold 1,198 shares @ $713.66, valued at $855k
Sold 1,022 shares @ $714.61, valued at $730.3k
Sold 2,266 shares @ $715.48, valued at $1.6M
Sold 311 shares @ $716.08, valued at $222.7k
Exercised 2,145 options to buy @ $374.12, valued at $802.5k
Exercised 3,613 options to buy @ $482.68, valued at $1.7M
12/13/2022 4 COLES N ANTHONY (CEO and Chairperson) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Sold 44,855 shares @ $26.617, valued at $1.2M
Sold 5,145 shares @ $27.0932, valued at $139.4k
Exercised 50,000 options to buy @ $3.5, valued at $175k
09/08/2022 4 COLES N ANTHONY (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Sold 300 shares @ $576.73, valued at $173k
Sold 500 shares @ $577.07, valued at $288.5k
Sold 273 shares @ $578.25, valued at $157.9k
Sold 550 shares @ $579.85, valued at $318.9k
Sold 688 shares @ $580.44, valued at $399.3k
Sold 822 shares @ $581.44, valued at $477.9k
Sold 1,220 shares @ $582.56, valued at $710.7k
Sold 1,045 shares @ $583.16, valued at $609.4k
Sold 602 shares @ $584.57, valued at $351.9k
Exercised 3,784 options to buy @ $371.4, valued at $1.4M
Exercised 2,216 options to buy @ $374.12, valued at $829k
02/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2022 4 COLES N ANTHONY (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Granted 191 shares @ $0
Granted 2,707 options to buy @ $625.6, valued at $1.7M
09/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2021 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
12/28/2020 4 COLES N ANTHONY (Executive Chair) has filed a Form 4 on YUMANITY THERAPEUTICS, INC.
Txns: Granted 689,890 shares @ $0
Granted 52,669 shares @ $0
Granted 72,496 options to buy @ $8.16, valued at $591.6k
Granted 12,082 options to buy @ $8.16, valued at $98.6k
Granted 6,038 warrants @ $24.05, valued at $145.2k
12/28/2020 3 COLES N ANTHONY (Executive Chair) has filed a Form 3 on YUMANITY THERAPEUTICS, INC.
11/13/2020 4 COLES N ANTHONY (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Exercised 11 options to buy @ $345.47, valued at $3.8k
10/30/2020 4 COLES N ANTHONY (President and CEO) has filed a Form 4 on Cerevel Therapeutics Holdings, Inc.
Txns: Granted 196,335 options to buy @ $9.88, valued at $1.9M
10/30/2020 3 COLES N ANTHONY (See Remarks) has filed a Form 3 on Cerevel Therapeutics Holdings, Inc.
08/19/2020 4 COLES N ANTHONY (Director) has filed a Form 4 on MCKESSON CORP
Txns: Sold 2,453 shares @ $156.771, valued at $384.6k
07/31/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2020 4 COLES N ANTHONY (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.
Txns: Granted 320 shares @ $0
Granted 4,361 options to buy @ $374.12, valued at $1.6M
08/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2019 4 COLES N ANTHONY (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS INC
Txns: Granted 323 shares @ $0
Granted 3,784 options to buy @ $371.4, valued at $1.4M
09/04/2018 4 COLES N ANTHONY (Director) has filed a Form 4 on MCKESSON CORP
Txns: Sold 1,350 shares @ $128.69, valued at $173.7k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy